Abstract：Abnormal phospholipid metabolism in the brain plays an important role in neuropsychiatric diseases. Phospholipase A2 (PLA2) is a crucial element for normal neuro-physiological function. This study aims to investigate the genetic association between the polymorphism of cytosolic phospholipase A2 (cPLA2) family genes and schizophrenia among Han Chinese in the northern part of China. The polymerase chain reaction-based ligase detection reaction (PCR-LDR) was applied to detect the genotype ten single nucleotide polymorphisms (SNPs) of cPLA2 family genes among 201 pedigrees consisting of fathers, mothers and affected offsprings with schizophrenia. The pedigrees were collected from 2000 to 2006. Haplotype relative risk (HRR) test, transmission disequilibrium test (TDT), haplotype transmission analysis and multiple locus analysis were conducted to analyze the genotyping data. The genotypic frequency of cPLA2 gene did not deviate from Hardy-Weinberg equilibrium either in case or control group. HRR and TDT showed that the ten SNPs were not associated with schizophrenia (P>0.05). Analysis for haplotype transmission showed that no haplotype system was associated with schizophrenia (P>0.05). The conditioning on allele (COA) and conditioning on gene (COG) tests showed disease associations with the haplotype of rs2162886-rs1668589, rs891014-rs1668589 and rs2307279-rs7542180 (χ2=6.913, P=0.032; χ2=8.393, P=0.015; χ2€=8.447, P=0.038). Our data suggest that many loci in the cPLA2 family genes may be associated with schizophrenia.
. Genetic association between the polymorphism
of cytosolic PLA2 gene family and schizophrenia[J]. Front. Med., 2010, 4(1): 101-105.
Qiong YU PhD, Xiang-Fei MENG PhD, Jie-Ping SHI, Ya-Qin YU PhD, . Genetic association between the polymorphism
of cytosolic PLA2 gene family and schizophrenia. Front. Med., 2010, 4(1): 101-105.
World Health Organization. WHO Health Report 2001-Mental Health: new understanding,new hope. World Health Organization, 2001: 33–34
World Health Organization. Mental Health around the World: Stop Exclusion Dare toCare, World Mental Health Day. 2001
United Nations PopulationDivision. World Population Prospects: The2002 Revision, Volume III, The AnalyticalReport
Murray C, Lopez A. The GlobalBurden of Disease: A Comprehensive Assessment of Mortality and Disabilityfrom Diseases, Injuries and Risk Factors in 1990 and Projected to2020. Cambridge, MA: Harvard University Press, 1996
Klemm S, Rzanny R, Riehemann S, Volz H P, Schmidt B, Gerhard U J, Filz C, Schönberg A, Mentzel H J, Kaiser W A, Blanz B. Cerebral phosphatemetabolism in first-degree relatives of patients with schizophrenia. Am J Psychiatry, 2001, 158(6): 958–960 doi: 10.1176/appi.ajp.158.6.958
Bennett C N, Horrobin D F. Gene targets related to phospholipids and fatty acid metabolism inschizophrenia and other psychiatric disorders: an update. Prostaglandins Leukot Essent Fatty Acids, 2000, 63(1,2): 47–59
Macdonald D J, Boyle R M, Glen A C, Ross B M, Glen A I, Ward P E, McKinney S B, Peterkin M A. The investigation of cytosolicphospholipase A2 using ELISA. ProstaglandinsLeukot Essent Fatty Acids, 2004, 70(4): 377–381 doi: 10.1016/j.plefa.2003.12.013
Kinney D K, Jacobsen B, Jansson L. Winter birth and biologicalfamily history in adopted schizophrenics. Schizophr Res, 2000, 44(2): 95–103 doi: 10.1016/S0920-9964(99)00162-0
Wei J, Hemmings G P. A study of a genetic association between the PTGS2/PLA2G4A locusand schizophrenia. Prostaglandins LeukotEssent Fatty Acids, 2004, 70(4): 413–415 doi: 10.1016/j.plefa.2003.12.018
Hudson C J, Kennedy J L, Gotowiec A, Lin A, King N, Gojtan K, Macciardi F, Skorecki K, Meltzer H Y, Warsh J J, Horrobin D F. Genetic variant near cytosolicphospholipase A2 associated with schizophrenia. Schizophr Res, 1996, 21(2): 111–116 doi: 10.1016/0920-9964(96)00031-X
Yu Y, Tao R, Shi J, Zhang X, Kou C, Guo Y, Zhang X, Lin X, Liu S, Ju G, Xu Q, Shang H, Shen Y, Wei J. Agenetic study of two calcium-independent cytosolic PLA2 genes in schizophrenia. Prostaglandins Leukot and Essent Fatty Acids, 2005, 73(5): 351–354 doi: 10.1016/j.plefa.2005.07.003
Gattaz W F, Brunner J. Phospholipase A2 and the hypofrontality hypothesis of schizophrenia. Prostaglandins Leukot Essent Fatty Acids, 1996, 55(1,2): 109–113
Pae C U, Yu H S, Lee K U, Kim J J, Lee C U, Lee S J, Jun T Y, Lee C, Paik I H. Ban I polymorphism of the cytosolic phospholipase A2 gene may confersusceptibility to the development of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry, 2004, 28(4): 739–741 doi: 10.1016/j.pnpbp.2004.05.009
Chowdari K V, Brandstaetter B, Semwal P, Bhatia T, Deshpande S, Reddy R, Wood J, Weinberg C R, Thelma B K, Nimgaonkar V L. Association studies of cytosolic phospholipase A2 polymorphismsand schizophrenia among two independent family-based samples. Psychiatr Genet, 2001, 11(4): 207–212 doi: 10.1097/00041444-200112000-00005
Frieboes R M, Moises H W, Gattaz W F, Yang L, Li T, Liu X, Vetter P, Macciardi F, Hwu H G, Henn F. Lack of associationbetween schizophrenia and the phospholipase-A(2) genes cPLA2 and sPLA2. Am J Med Genet, 2001, 105(3): 246–249 doi: 10.1002/ajmg.1262
